Hidden Blood Loss and Its Influential Factors After Total Hip Arthroplasty

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2015 Apr 19

PMID 25889223

Citations 55

Authors

Kaisong Miao

Su Ni

Xianju Zhou

Nanwei Xu

Rongbin Sun

Chao Zhuang

Yuji Wang

Affiliations

Soon will be listed here.

Abstract

Background: Total hip arthroplasty (THA) is a vital therapy for various hip joint diseases. However, patients have lower hemoglobin level post-operatively, remarkably inconsistent with the measured blood loss. The inconsistence is majorly attributed to hidden blood loss (HBL). In this study, we investigated the HBL and its influential factors among patients after THA.

Methods: From January 2008 to June 2014, 322 patients (99 males and 223 females) undergoing THA were enrolled in this study. All patients were assessed comprehensively before the operation. The demographic information of the patients was collected. Intra-operative and post-operative blood loss was recorded, and then, the total perioperative blood loss and the HBL were calculated. Influential factors were further analyzed by multiple and stepwise regression.

Results: The HBL was 429 ± 223 mL, with a percentage of 35.4% ± 11.0% in the total perioperative blood loss (1,155 ± 377 mL). Multiple and stepwise regression analysis revealed that HBL was positively associated with body mass index (BMI), blood transfusion volume, length of incision, change of hematocrit (HCT) between pre-operation and post-operation but negatively associated with age. As compared to male patients, female patients had a risk of increased HBL. Development displasia hip (DDH) patients had a less risk of HBL in all patients.

Conclusion: HBL is a significant portion of total blood loss in the patients after THA. Gender, age, BMI, blood transfusion, length of incision, change of HCT, and diagnosis are influential factors of HBL.

Citing Articles

Risk factors for hidden blood loss in unilateral biportal endoscopic lumbar interbody fusion : a single-center retrospective study.

Jin J, Chen H, Peng Y, Dai J, Wang Q, Yan J BMC Musculoskelet Disord. 2024; 25(1):1017.

PMID: 39695594 PMC: 11657688. DOI: 10.1186/s12891-024-08104-7.

Hidden blood loss of minimally invasive transforaminal lumbar interbody fusion of lumbar degenerative diseases in patients with osteoporosis: a retrospective study.

Lin S, Liu S, Li Y, Yan Y, Ye H J Orthop Surg Res. 2024; 19(1):798.

PMID: 39593090 PMC: 11600765. DOI: 10.1186/s13018-024-05297-4.

Comprehensive Analysis of UBE-Related Complications: Prevention and Management Strategies from 4685 Patients.

Yang L, Yu T, Jiao J, Hou T, Wang Y, Zhao B Med Sci Monit. 2024; 30:e944018.

PMID: 39385451 PMC: 11476038. DOI: 10.12659/MSM.944018.

Outcomes of Hip Arthroplasty in Patients with Preoperative Thrombocytopenia.

Go J, Han M, Kim T, Park B, Park J, Lee Y Clin Orthop Surg. 2024; 16(5):711-717.

PMID: 39364110 PMC: 11444954. DOI: 10.4055/cios24082.

Efficacy and safety of tranexamic acid use in elderly patients undergoing anterior cervical discectomy and fusion: a retrospective study.

Lou Z, Jiang Y, Jiang K, Zhu J, Lai L, Huang Z J Int Med Res. 2024; 52(9):3000605241285661.

PMID: 39340253 PMC: 11445765. DOI: 10.1177/03000605241285661.

References

Chang C, Chang Y, Chen D, Ueng S, Lee M . Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty. Clin Orthop Relat Res. 2014; 472(5):1552-7. PMC: 3971210. DOI: 10.1007/s11999-013-3446-0. View

Zhou X, Li J, Xiong Y, Jiang L, Li W, Wu L . Do we really need closed-suction drainage in total hip arthroplasty? A meta-analysis. Int Orthop. 2013; 37(11):2109-18. PMC: 3824906. DOI: 10.1007/s00264-013-2053-8. View

Pattison E, Protheroe K, Pringle R, Kennedy A, Dick W . Reduction in haemoglobin after knee joint surgery. Ann Rheum Dis. 1973; 32(6):582-4. PMC: 1006172. DOI: 10.1136/ard.32.6.582. View

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H . Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am. 2013; 95(21):1969-74. DOI: 10.2106/JBJS.L.00908. View

Aguilera-Roig X, Jordan-Sales M, Natera-Cisneros L, Monllau-Garcia J, Martinez-Zapata M . [Tranexamic acid in orthopedic surgery]. Rev Esp Cir Ortop Traumatol. 2013; 58(1):52-6. DOI: 10.1016/j.recot.2013.08.005. View

Faris P, Ritter M, Keating E, Valeri C . Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells. J Bone Joint Surg Am. 1991; 73(8):1169-78. View

Yue C, Kang P, Yang P, Xie J, Pei F . Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty. 2014; 29(12):2452-6. DOI: 10.1016/j.arth.2014.03.032. View

Cushner F, Friedman R . Blood loss in total knee arthroplasty. Clin Orthop Relat Res. 1991; (269):98-101. View

Gross J . Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983; 58(3):277-80. DOI: 10.1097/00000542-198303000-00016. View

10.

Sehat , Evans , Newman . How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account. Knee. 2000; 7(3):151-155. DOI: 10.1016/s0968-0160(00)00047-8. View

11.

Borgen P, Dahl O, Reikeras O . Blood loss in cemented THA is not reduced with postoperative versus preoperative start of thromboprophylaxis. Clin Orthop Relat Res. 2012; 470(9):2591-8. PMC: 3830101. DOI: 10.1007/s11999-012-2320-9. View

12.

Zhou X, Tao L, Li J, Wu L . Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg. 2013; 133(7):1017-27. DOI: 10.1007/s00402-013-1761-2. View

13.

Rosencher N, Kerkkamp H, Macheras G, Munuera L, Menichella G, Barton D . Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43(4):459-69. DOI: 10.1046/j.1537-2995.2003.00348.x. View

14.

Eriksson B, Dahl O, Buller H, Hettiarachchi R, Rosencher N, Bravo M . A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost. 2005; 3(1):103-11. DOI: 10.1111/j.1538-7836.2004.01100.x. View

15.

Bao N, Zhou L, Cong Y, Guo T, Fan W, Chang Z . Free fatty acids are responsible for the hidden blood loss in total hip and knee arthroplasty. Med Hypotheses. 2013; 81(1):104-7. DOI: 10.1016/j.mehy.2013.03.038. View

16.

Erskine J, Fraser C, Simpson R, Protheroe K, Walker I . Blood loss with knee joint replacement. J R Coll Surg Edinb. 1981; 26(5):295-7. View

17.

Shen H, Li Z, Feng M, Cao G . Analysis on hidden blood loss of total knee arthroplasty in treating knee osteoarthritis. Chin Med J (Engl). 2011; 124(11):1653-6. View

18.

Li J, Zhou Y, Jing J, Zhan J . [Comparison of effects of two anticoagulants on hidden blood loss after total hip arthroplasty]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013; 27(4):432-5. View

19.

Prasad N, Padmanabhan V, Mullaji A . Blood loss in total knee arthroplasty: an analysis of risk factors. Int Orthop. 2006; 31(1):39-44. PMC: 2267526. DOI: 10.1007/s00264-006-0096-9. View

20.

Konig G, Hamlin B, Waters J . Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty. 2013; 28(9):1473-6. PMC: 3807723. DOI: 10.1016/j.arth.2013.06.011. View